Citryll B.V.

4 trials 3 recruiting Commercial sponsor

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

1 Completed trials

5 Countries active

3 Unique IMPs

100% Results reported

Phase II

Phase I (Other)

Phase II: 3 Phase I (Other): 1

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

CIT-013 2 [89ZR]ZR-DFO-CIT-013 1 SODIUM CHLORIDE 1

All trials

4 total

150 mg CIT-013 phase 1 trial Recruiting

2026-526153-34-00 Phase I (Other) 1 country
PET-Based Imaging of Radiolabeled CIT-013 Recruiting

2025-522189-60-00 Phase II 1 country [89ZR]ZR-DFO-CIT-013
A Phase 2a double blind, randomized, parallel arm, placebo-controlled trial to investigate the effects of two dose levels of CIT-013 on dise… Recruiting

2025-521684-12-00 Phase II 4 countries CIT-013
Proof of Concept trial with CIT-013 in Rheumatoid Arthritis Ended

2024-517356-35-00 Phase II 5 countries CIT-013; SODIUM CHLORIDE

Showing 1–4 of 4 trials

← All sponsors A–Z